Commentaries by date:

Assessing Janus Kinase Inhibitor’s Place in Therapy in Established Rheumatoid Arthritis Patients-From a Simplified Indirect Comparison Versus Tumor Necrosis Factor Inhibitors to a Bayesian Probability of Response-The Value Of Transparency

By GROWTH | October 30, 2013

AUTHORS: Ingham, M.P., Song, P., Cartier, S., Lawson-Remer, K. and Murray, E. Publication: Arthritis and Rheumatism. Vol. 65. 111 River St, Hoboken…

Read More

Assessing Janus Kinase Inhibitor’s Place in Therapy in Established Rheumatoid

By GROWTH | October 17, 2013

AUTHOR: Ingham, M.P., Song, P., Cartier, S., Lawson-Remer, K. and Murray, E. CONFERENCE: Academy of Managed Care Pharmacy (AMCP) meeting, San Diego,…

Read More

Methods for Comparative Effectiveness Research

By GROWTH | October 19, 2012

AUTHOR: Wei, W., Frimpter, J., Edwardson, K., Mitchell, D., and Savella, M.G. CONFERENCE: Society for Medical Decision Making. Phoenix, AZ. DATE: Oct 17-20,…

Read More

Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma

By GROWTH | December 11, 2011

AUTHORS: Berenson, K.L., Kymes, S., Hollander, D.A., Fiscella, R., Burk, C. and Patel, V.D. Publication: The American journal of managed care 17.9…

Read More

Demonstration of an Online Tool to Assist Care Formulary Evidence-based Decision-making: Meta-analysis of Topical Prostaglandin Analog Efficacy

By GROWTH | July 11, 2011

AUTHORS: Kymes, S.M., Burk, C., Feinman, T., Williams, J.M. and Hollander, D.A. Publication: ITherapeutics and Clinical Risk Management, 2011; 7: 283–290. Published…

Read More